Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Assets (2017 - 2025)

Acro Biomedical has reported Return on Assets over the past 9 years, most recently at 10.98% for Q4 2025.

  • Quarterly results put Return on Assets at 10.98% for Q4 2025, down 978.0% from a year ago — trailing twelve months through Dec 2025 was 10.98% (down 978.0% YoY), and the annual figure for FY2025 was 4.39%, down 346.0%.
  • Return on Assets for Q4 2025 was 10.98% at Acro Biomedical, down from 5.36% in the prior quarter.
  • Over the last five years, Return on Assets for ACBM hit a ceiling of 0.27% in Q1 2021 and a floor of 227.33% in Q4 2023.
  • Median Return on Assets over the past 5 years was 9.17% (2022), compared with a mean of 26.67%.
  • Biggest five-year swings in Return on Assets: plummeted -20349bps in 2023 and later soared 22614bps in 2024.
  • Acro Biomedical's Return on Assets stood at 2.33% in 2021, then crashed by -925bps to 23.85% in 2022, then crashed by -853bps to 227.33% in 2023, then surged by 99bps to 1.2% in 2024, then crashed by -817bps to 10.98% in 2025.
  • The last three reported values for Return on Assets were 10.98% (Q4 2025), 5.36% (Q3 2025), and 1.19% (Q2 2025) per Business Quant data.